- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02656108
Omission of Controlled Cord Traction During Active Management of Third Stage of Labor
October 14, 2018 updated by: Ahmed Mohamed El Kotb Abdel Fattah, Ain Shams University
Omission of Controlled Cord Traction During Active Management of Third Stage of Labor. A Single Blinded Randomized Controlled Trial
This is a comparative study which will be conducted in Ain Shams University Maternity hospital to assess the individual and specfic role of controlled cord traction as a part of active management of third stage of labor
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
300 patients will be randomized into two groups with controlled cord traction and withoout.
The primary outcome will be sever postpartum haemorrhage
Study Type
Interventional
Enrollment (Anticipated)
320
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Al Qahirah
-
Cairo, Al Qahirah, Egypt
- Recruiting
- Faculty of Medicine, Ain Shams University
-
Contact:
- ahmed kotb, MD
- Phone Number: 2001008681999
- Email: ahmedmkotp@hotmail.com
-
Contact:
- ahmed kotb
- Email: ahmedmkotp@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- singleton pregnancy
- term pregnancy
Exclusion Criteria:
- episiotomy
- operative vaginal delivery
- known coagulation defect
- Acute complication during labor e.g. eclampsia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: omiited controlled cord traction
neither controlled cord traction nor fundal pressure will be applied.
The placenta will be delivered physiologically and signs of placental separation will be awaited
|
No controlled cord traction and no fundal pressure.
placenta will be allowed to deliver physiologically
|
|
Active Comparator: controlled cord traction
the cord will be held in one hand and the other hand will be placed just above the woman's pubic boneto stabilize the uterus during cord traction
|
active management of third stage of labor in the form of uterine massage with controlled cord traction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sever post partum haemorrhage
Time Frame: 24 hours
|
blood loss more than 500 cc
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
duration of third stage of labor
Time Frame: 30 minutes
|
from delivery of the baby to delivery of the placenta
|
30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ahmed M kotb, MD, Ain Shams University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2018
Primary Completion (Anticipated)
November 1, 2018
Study Completion (Anticipated)
November 1, 2018
Study Registration Dates
First Submitted
January 12, 2016
First Submitted That Met QC Criteria
January 12, 2016
First Posted (Estimate)
January 14, 2016
Study Record Updates
Last Update Posted (Actual)
October 17, 2018
Last Update Submitted That Met QC Criteria
October 14, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- CCO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor Stage, Third
-
Ataturk UniversityCompletedOxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester AbortionAbortion, Induced | Pregnancy Trimester, Second | Labor Stage, Third/Drug Effects | Oxytocin/Administration & DosageTurkey
-
Shaare Zedek Medical CenterCompleted
-
Vanderbilt UniversitySigma Theta Tau International, Iota chapter; Sigma Theta Tau International,... and other collaboratorsCompletedBleeding | Childbirth | Third Stage of Labor | Guided ImageryUnited States
-
Kanuni Sultan Suleyman Training and Research HospitalCompleted
-
Mersin UniversityCompletedHealthy | Infant Conditions | Third Stage of Labor | Umbilical Cord Clamping TimeTurkey
-
HaEmek Medical Center, IsraelCompleted
-
Memorial University of NewfoundlandCompletedThird Stage of LabourCanada
-
CMH Multan Institute of Medical SciencesCompletedOxytocin | Third Stage of Labour | Postpartum BleedingPakistan
-
Rabin Medical CenterUnknownLabor, First Stage | Labor, Second StageIsrael
-
Hillel Yaffe Medical CenterNot yet recruitingPregnancy | Labor | Second Stage of Labor
Clinical Trials on Ommited controlled cord traction
-
Universidad de la RepublicaInstitute for Clinical Effectiveness and Health Policy; Unidad de Investigación...Completed
-
Haydarpasa Numune Training and Research HospitalCompletedCesarean Section ComplicationsTurkey
-
Busra LekesizNot yet recruitingCesarean Section Complications | Postpartum Hemorrhage | Uterine Atony
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; URC-CIC...CompletedPostpartum Haemorrhage | Immediate Postpartum HemorrhageFrance
-
Benha UniversityArmed Forces Hospitals, Southern Region, Saudi ArabiaCompletedComplications; Cesarean SectionSaudi Arabia
-
Chinese PLA General HospitalCompletedType 2 Diabetes | Mesenchymal Stem CellsChina
-
Ever Supreme Bio Technology Co., Ltd.Active, not recruiting
-
Stanford UniversityRecruitingChronic Pelvic Pain SyndromeUnited States
-
Christiana Care Health ServicesCompleted
-
McMaster UniversityHeart and Stroke Foundation of OntarioCompleted